ResMed Inc.（NYSE:RMD）首席执行官Michael J. Farrell最近出售了2,000股公司普通股。这些股票以平均每股249.665美元的价格售出，总计约499,330美元。此次交易后，这些股份由Lisette and Michael Farrell Foundation持有，首席执行官保留对这些股份的处置权。

It was reported on November 27, that Michael J Farrell, Chief Executive Officer at ResMed RMD executed a significant insider ...

Shares of ResMed Inc. RMD slipped 0.26% to $249.33 Wednesday, on what proved to be an all-around rough trading session for ...

What Happened: In a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, Farrell, Chief Executive Officer at ResMed, acquired stock options for 33,036 shares of RMD. These ...

圣地亚哥——根据最近的SEC文件，ResMed Inc.（NYSE:RMD）首席产品官Justin Leong已出售了6,160股公司普通股。这笔交易发生在11月22日，股票以加权平均价243.087美元售出，总计约1,497,415美元。 在此次出售之后，Leong仍持有ResMed的21,718股股份。此次出售通过多笔交易完成，每股价格在243.00美元至243.315美元之间。 总部位于圣地 ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...

Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...

Up 63% in a year, ResMed Inc (ASX: RMD) shares are marching higher again on Monday. Here’s why the company’s been making news ...

With a market cap of $35.8 billion, ResMed Inc. (RMD) is a global leader in the design, manufacturing, and distribution of ...

器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注 2024年11月15日，全球睡眠健康创导者瑞思迈（ResMed）在中国市场正式推出 ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...

ResMed shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82. Meet the ...